Afya Limited (NASDAQ:AFYA) Receives $17.20 Consensus Target Price from Brokerages

Shares of Afya Limited (NASDAQ:AFYAGet Free Report) have earned a consensus recommendation of “Hold” from the eight brokerages that are covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and one has issued a buy recommendation on the company. The average 12-month target price among brokerages that have covered the stock in the last year is $17.10.

Several research analysts recently commented on the stock. Zacks Research downgraded shares of Afya from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, May 6th. Bank of America reiterated a “neutral” rating on shares of Afya in a report on Thursday, June 11th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Afya in a research note on Monday, April 20th. JPMorgan Chase & Co. cut their target price on shares of Afya from $21.50 to $21.00 and set a “neutral” rating on the stock in a research note on Monday. Finally, Wall Street Zen lowered shares of Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 2nd.

View Our Latest Analysis on AFYA

Afya Stock Up 1.1%

Shares of NASDAQ AFYA opened at $14.36 on Wednesday. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.42. Afya has a 52 week low of $13.00 and a 52 week high of $18.16. The firm’s fifty day moving average is $14.40 and its 200 day moving average is $14.52. The company has a market cap of $1.35 billion, a price-to-earnings ratio of 9.39, a PEG ratio of 1.46 and a beta of 0.34.

Insider Activity

In other news, VP Lelio De Souza Junior sold 16,279 shares of Afya stock in a transaction dated Thursday, April 9th. The shares were sold at an average price of $14.53, for a total transaction of $236,533.87. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP De Sousa Anibal Jose Grifo sold 14,000 shares of Afya stock in a transaction dated Monday, April 13th. The shares were sold at an average price of $15.41, for a total transaction of $215,740.00. Following the sale, the vice president directly owned 31,000 shares in the company, valued at $477,710. The trade was a 31.11% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 119,647 shares of company stock worth $1,795,718.

Institutional Trading of Afya

Hedge funds have recently modified their holdings of the business. Swedbank AB boosted its holdings in shares of Afya by 170.3% during the 4th quarter. Swedbank AB now owns 189,200 shares of the company’s stock valued at $2,916,000 after buying an additional 119,200 shares in the last quarter. SPX Gestao de Recursos Ltda bought a new stake in shares of Afya during the 3rd quarter valued at $2,895,000. Doma Perpetual Capital Management LLC boosted its holdings in shares of Afya by 50.6% during the 3rd quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after buying an additional 299,419 shares in the last quarter. Daiwa Securities Group Inc. bought a new stake in shares of Afya during the 4th quarter valued at $43,000. Finally, Fairtree Asset Management Pty Ltd boosted its stake in Afya by 22.3% in the 4th quarter. Fairtree Asset Management Pty Ltd now owns 30,697 shares of the company’s stock worth $473,000 after purchasing an additional 5,599 shares in the last quarter. Institutional investors own 88.02% of the company’s stock.

Afya Company Profile

(Get Free Report)

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.

Further Reading

Analyst Recommendations for Afya (NASDAQ:AFYA)

Receive News & Ratings for Afya Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Afya and related companies with MarketBeat.com's FREE daily email newsletter.